Placement Announced
Ensysce Biosciences placement
US$43m raised
Announced 6 Aug 2026 · NASDAQ: ENSC · US$321.79 cash per share
Advisers
Ensysce Biosciences
Issuer
Not disclosed
Lead managers
- Legal adviser
- Placement agent
- Issuer
- Ensysce Biosciences
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Adial Pharmaceuticals placement Jun 2026 · US$32m · Biotech
- Skye Bioscience placement Aug 2026 · US$68m · Biotech
- Parabilis Medicines placement Jun 2026 · US$75m · Biotech
- Odyssey Therapeutics placement May 2026 · US$25m · Biotech
- ADARx Pharmaceuticals placement Sep 2026 · US$89m · Biotech
